Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease

Conditions:   Multiple Myeloma;   Extramedullary Plasmacytoma Interventions:   Drug: Daratumumab;   Drug: Bortezomib;   Drug: Cyclophosphamide;   Drug: Dexamethasone Sponsors:   European Myeloma Network;   Janssen, LP Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials